Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) Short Interest Up 207.1% in January

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ) saw a significant growth in short interest in the month of January. As of January 15th, there was short interest totalling 4,300 shares, a growth of 207.1% from the December 31st total of 1,400 shares. Based on an average daily volume of 11,200 shares, the short-interest ratio is presently 0.4 days.

Invesco Nasdaq Biotechnology ETF Stock Up 0.8 %

NASDAQ IBBQ traded up $0.17 on Thursday, reaching $22.65. The stock had a trading volume of 4,466 shares, compared to its average volume of 7,235. The stock has a fifty day moving average price of $22.20 and a two-hundred day moving average price of $23.25. Invesco Nasdaq Biotechnology ETF has a 12-month low of $20.14 and a 12-month high of $24.84. The firm has a market capitalization of $40.09 million, a price-to-earnings ratio of 17.39 and a beta of 0.61.

Invesco Nasdaq Biotechnology ETF Announces Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 27th. Shareholders of record on Monday, December 23rd were given a $0.0619 dividend. The ex-dividend date was Monday, December 23rd.

Institutional Investors Weigh In On Invesco Nasdaq Biotechnology ETF

Institutional investors have recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of Invesco Nasdaq Biotechnology ETF by 22.7% during the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 259,733 shares of the company’s stock worth $6,156,000 after buying an additional 48,137 shares in the last quarter. Strategic Financial Concepts LLC acquired a new stake in Invesco Nasdaq Biotechnology ETF during the 4th quarter valued at $1,699,000. Finally, ORG Partners LLC purchased a new position in Invesco Nasdaq Biotechnology ETF in the 3rd quarter valued at about $25,000.

About Invesco Nasdaq Biotechnology ETF

The Invesco Nasdaq Biotechnology ETF (IBBQ) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index, a modified market-cap-weighted index of US biotechnology and pharmaceutical companies listed on the NASDAQ. IBBQ was launched on Jun 11, 2021 and is managed by Invesco.